Stock listing
gettex:NPAU BetterLife Pharma Inc. Aktie
German listing (gettex) of BetterLife Pharma Inc. · home listing CSE:BETR
Follow BetterLife Pharma Inc. into a list and get an email when it puts out news.
Home listing price · CSE:BETR
$0.20 CAD -0.01 (-4.8%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:BETR
- Day range
- $0.20 – $0.215 CADOct 20, 2026
- Volume
- 144,800 sharesOct 20, 2026
- Market cap
- $123.6M CADAt the close on Oct 20, 2026 · price × 618.0M shares outstanding
- 52-week range
- $0.04 – $0.46 CADLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:BETR · Home | $0.20 CAD | -0.01 (-4.8%) | 144,800 | $0.21 | $0.215 | $0.20 | $0.21 | Close on Oct 20, 2026 |
| OTC:BETRF | $0.159 USD | +0.000 (+0.1%) | 20,000 | $0.159 | $0.159 | $0.159 | $0.159 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · CSE:BETR · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.20 | -0.01 | -4.8% | $0.21 | $0.215 | $0.20 | 144,800 | |
| $0.21 | 0.00 | 0.0% | $0.21 | $0.225 | $0.21 | 116,326 | |
| $0.21 | -0.015 | -6.7% | $0.23 | $0.23 | $0.21 | 467,301 | |
| $0.225 | +0.005 | +2.3% | $0.225 | $0.23 | $0.22 | 132,057 | |
| $0.22 | -0.025 | -10.2% | $0.25 | $0.25 | $0.22 | 456,300 | |
| $0.245 | -0.01 | -3.9% | $0.26 | $0.26 | $0.245 | 300,607 | |
| $0.255 | -0.015 | -5.6% | $0.28 | $0.28 | $0.255 | 314,343 | |
| $0.27 | +0.01 | +3.8% | $0.26 | $0.27 | $0.25 | 311,500 | |
| $0.26 | -0.005 | -1.9% | $0.26 | $0.27 | $0.26 | 129,967 | |
| $0.265 | -0.025 | -8.6% | $0.295 | $0.295 | $0.265 | 269,089 | |
| $0.29 | +0.025 | +9.4% | $0.29 | $0.29 | $0.27 | 30,701 | |
| $0.265 | -0.005 | -1.9% | $0.27 | $0.285 | $0.265 | 372,951 | |
| $0.27 | -0.075 | -21.7% | $0.315 | $0.32 | $0.27 | 921,958 | |
| $0.345 | +0.06 | +21.1% | $0.30 | $0.345 | $0.29 | 73,010 | |
| $0.285 | -0.025 | -8.1% | $0.315 | $0.315 | $0.285 | 283,489 | |
| $0.31 | -0.025 | -7.5% | $0.33 | $0.33 | $0.305 | 319,050 | |
| $0.335 | -0.015 | -4.3% | $0.35 | $0.355 | $0.33 | 198,701 | |
| $0.35 | +0.015 | +4.5% | $0.335 | $0.35 | $0.335 | 184,428 | |
| $0.335 | +0.015 | +4.7% | $0.335 | $0.345 | $0.33 | 181,700 | |
| $0.32 | +0.015 | +4.9% | $0.32 | $0.33 | $0.305 | 209,113 | |
| $0.305 | -0.025 | -7.6% | $0.335 | $0.35 | $0.30 | 1,535,561 | |
| $0.33 | -0.03 | -8.3% | $0.355 | $0.36 | $0.33 | 248,618 | |
| $0.36 | 0.00 | 0.0% | $0.35 | $0.39 | $0.34 | 861,522 | |
| $0.36 | -0.02 | -5.3% | $0.39 | $0.39 | $0.35 | 505,800 | |
| $0.38 | -0.02 | -5.0% | $0.40 | $0.40 | $0.36 | 392,698 | |
| $0.40 | +0.06 | +17.6% | $0.34 | $0.40 | $0.34 | 1,124,392 | |
| $0.34 | +0.035 | +11.5% | $0.315 | $0.34 | $0.315 | 184,786 | |
| $0.305 | +0.005 | +1.7% | $0.30 | $0.31 | $0.30 | 264,000 | |
| $0.30 | -0.005 | -1.6% | $0.305 | $0.305 | $0.30 | 44,015 | |
| $0.305 | +0.005 | +1.7% | $0.305 | $0.305 | $0.30 | 31,533 | |
| $0.30 | 0.00 | 0.0% | $0.305 | $0.305 | $0.30 | 615,167 | |
| $0.30 | +0.015 | +5.3% | $0.285 | $0.31 | $0.28 | 892,540 | |
| $0.285 | -0.005 | -1.7% | $0.295 | $0.295 | $0.28 | 195,000 | |
| $0.29 | 0.00 | 0.0% | $0.31 | $0.31 | $0.28 | 116,316 | |
| $0.29 | -0.025 | -7.9% | $0.325 | $0.325 | $0.29 | 854,369 | |
| $0.315 | +0.005 | +1.6% | $0.345 | $0.345 | $0.29 | 590,644 | |
| $0.31 | -0.06 | -16.2% | $0.35 | $0.355 | $0.30 | 2,554,040 | |
| $0.37 | -0.01 | -2.6% | $0.375 | $0.38 | $0.35 | 39,195 | |
| $0.38 | +0.06 | +18.8% | $0.32 | $0.38 | $0.30 | 441,701 | |
| $0.32 | -0.005 | -1.5% | $0.32 | $0.32 | $0.295 | 238,893 | |
| $0.325 | +0.01 | +3.2% | $0.32 | $0.33 | $0.30 | 266,880 | |
| $0.315 | -0.035 | -10.0% | $0.315 | $0.34 | $0.31 | 169,019 | |
| $0.35 | -0.01 | -2.8% | $0.35 | $0.365 | $0.33 | 253,151 | |
| $0.36 | +0.06 | +20.0% | $0.30 | $0.36 | $0.295 | 143,750 | |
| $0.30 | +0.015 | +5.3% | $0.27 | $0.30 | $0.27 | 78,374 | |
| $0.285 | -0.015 | -5.0% | $0.29 | $0.295 | $0.265 | 251,739 | |
| $0.30 | -0.015 | -4.8% | $0.31 | $0.32 | $0.30 | 58,150 | |
| $0.315 | +0.03 | +10.5% | $0.305 | $0.315 | $0.29 | 48,275 | |
| $0.285 | -0.02 | -6.6% | $0.31 | $0.35 | $0.285 | 435,952 | |
| $0.305 | -0.12 | -28.2% | $0.44 | $0.445 | $0.30 | 742,591 | |
| $0.425 | +0.025 | +6.2% | $0.42 | $0.46 | $0.41 | 919,452 | |
| $0.40 | +0.035 | +9.6% | $0.36 | $0.40 | $0.35 | 504,343 | |
| $0.365 | +0.005 | +1.4% | $0.355 | $0.365 | $0.34 | 358,154 | |
| $0.36 | +0.07 | +24.1% | $0.30 | $0.36 | $0.30 | 1,036,722 | |
| $0.29 | +0.05 | +20.8% | $0.25 | $0.295 | $0.25 | 528,230 | |
| $0.24 | +0.01 | +4.3% | $0.205 | $0.24 | $0.205 | 43,590 | |
| $0.23 | 0.00 | 0.0% | $0.23 | $0.23 | $0.22 | 104,582 | |
| $0.23 | -0.01 | -4.2% | $0.24 | $0.24 | $0.23 | 77,500 | |
| $0.24 | +0.03 | +14.3% | $0.22 | $0.25 | $0.22 | 348,319 | |
| $0.21 | +0.01 | +5.0% | $0.195 | $0.21 | $0.195 | 105,788 | |
| $0.20 | -0.03 | -13.0% | $0.235 | $0.235 | $0.20 | 151,716 | |
| $0.23 | -0.005 | -2.1% | $0.23 | $0.24 | $0.23 | 78,500 | |
| $0.235 | +0.005 | +2.2% | $0.23 | $0.24 | $0.23 | 69,571 | |
| $0.23 | +0.015 | +7.0% | $0.215 | $0.25 | $0.215 | 40,048 |
- Ticker
- gettex:NPAU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 18 slides
Latest news
BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
Oct 19, 2026
Closed $0.21 (0.0%) on Oct 19, 2026
BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations
Oct 15, 2026
Closed $0.225 (+2.3%) on Oct 15, 2026
BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair
Oct 14, 2026
Closed $0.22 (-10.2%) on Oct 14, 2026
BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha
Oct 9, 2026
Closed $0.255 (-5.6%) on Oct 9, 2026
Kaplan Fox Reminds Better Home & Finance Holding Company (BETR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 20, 2026
Oct 1, 2026
Closed $0.265 (-1.9%) on Oct 2, 2026
BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting
Sep 29, 2026
Closed $0.345 (+21.1%) on Sep 30, 2026
Better Home & Finance (BETR) Faces Securities Class Action Amid 75% Sequential Increase in Net Loss, Dimmed Loan Volume Prospects
Sep 28, 2026
Closed $0.285 (-8.1%) on Sep 29, 2026
Better Home & Finance Opens Investigation into Serious Allegations of Breach of Fiduciary Duty by Director and Former CEO Vishal Garg
Sep 23, 2026
Closed $0.35 (+4.5%) on Sep 24, 2026
Better Home & Finance Calls on Former CEO Vishal Garg to End His Failed Revenge Campaign After He Again Extends Deadline for Consent Solicitation
Sep 18, 2026
Closed $0.33 (-8.3%) on Sep 18, 2026
BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Sep 17, 2026
Closed $0.36 (0.0%) on Sep 17, 2026
Financings
Public offering of common shares and pre-funded warrants
Sep 17, 2026
Closed: US$100M raised · C$0.25 a share · Bloom Burton Securities Inc. +1
Dealers: Bloom Burton Securities Inc. (lead), Haywood Securities Inc.
Buyers: Deep Track Capital (led the financing); Coastlands Capital (significant co-investment); Marshall Wace (significant co-investment); RA Capital Management (significant co-investment); Perceptive Advisors (significant co-investment); Adage Capital Management (participation); Affinity Asset Advisors (participation); Kalehua Capital (participation); Sphera Fund Management (participation); Squadron Capital Management (participation); Stonepine Capital Management (participation); Woodline Partners LP (participation)
Use of proceeds: Phase 1A, Phase 1B and Phase 2 clinical trials of BETR-001 in cluster headache and migraine, plus working capital and general corporate purposes
Announced Aug 24, 2026 · Terms changed Aug 28, 2026 · Closed Sep 17, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 18 slides · July 2026
Investor Presentation (January 2023)
Investor deck · 15 slides · Jan 13, 2023
Investor Presentation (August 2022)
Investor deck · 15 slides · August 2022
Investor Presentation (December 2021)
Investor deck · 23 slides · December 2021
BetterLife Pharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 74 in the last 12 months · 160 in all · newest Oct 19, 2026 · oldest 2011
- Decks
- 5 decks · latest July 2026
Where BetterLife Pharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:BETR · Home listing | CSE | Canada | CAD |
| OTC:BETRF | OTC | United States | USD |
| Cboe Canada:BETR | Cboe Canada | Canada | CAD |
| Frankfurt:NPAU | Frankfurt | Germany | EUR |
| LS Exchange:A2P7XN | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2P7XN | Lang & Schwarz | Germany | EUR |
| gettex:NPAU · This page | gettex | Germany | EUR |
| Stuttgart:NPAU | Stuttgart | Germany | EUR |
| Munich:NPAU | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about BetterLife Pharma Inc.